NEW YORK (GenomeWeb) — Thermo Fisher Scientific announced today that it has received CE-IVD marking for its Oncomine Dx Target Test.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.
This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.
This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.